scholarly journals Dialysis Arteriovenous Fistula Causing Subclavian Steal Syndrome in the Absence of Subclavian Artery Stenosis

2015 ◽  
Vol 2015 ◽  
pp. 1-4 ◽  
Author(s):  
Eesha Maiodna ◽  
Sudheer Ambekar ◽  
Jeremiah N. Johnson ◽  
Mohamed Samy Elhammady
Keyword(s):  
Arteriovenous Fistula ◽  
End Stage Renal Disease ◽  
Subclavian Steal Syndrome ◽  
External Compression ◽  
Subclavian Steal ◽  
Retrograde Filling ◽  
Flow Through ◽  
Stage Renal Disease ◽  
End Stage ◽  
Steal Syndrome

We present a rare cause of subclavian steal syndrome secondary to a dialysis arteriovenous fistula (AVF). A 69-year-old female with end-stage renal disease presented with ataxia and recurrent fainting spells. Angiography revealed normal subclavian arteries bilaterally, a right VA origin occlusion, and an apparent left VA origin occlusion. However, carotid artery angiography demonstrated flow through the posterior communicating artery with retrograde filling of the basilar artery and left VA to its subclavian origin. Repeat left subclavian arteriography during external compression of the AVF demonstrated normal antegrade left VA flow. The AVF was subsequently ligated resulting in complete symptom resolution.

Blurring of vision in subclavian steal syndrome associated with an upper arm arteriovenous fistula

2017 ◽  
Vol 18 (2) ◽  
pp. e20-e21 ◽  
Author(s):  
Usman K. Hayat ◽  
Aurang Z. Khawaja ◽  
Robert G. Jones ◽  
Nicholas G. Inston
Keyword(s):  
Arteriovenous Fistula ◽  
Subclavian Steal Syndrome ◽  
Upper Arm ◽  
Subclavian Steal ◽  
Steal Syndrome

Clinical Considerations in Hemodialysis Access Intervention

2018 ◽  
pp. 594-614
Author(s):  
Eric K. Hoffer
Keyword(s):  
Renal Disease ◽  
Arteriovenous Fistula ◽  
End Stage Renal Disease ◽  
Morbidity And Mortality ◽  
Dialysis Access ◽  
Hemodialysis Access ◽  
National Kidney Foundation ◽  
Clinical Considerations ◽  
Stage Renal Disease ◽  
End Stage

Interventional radiologists developed and refined the endovascular approaches to maintenance of the permanent arteriovenous vascular accesses that are integral to the provision of hemodialysis for patients with end stage renal disease. As methods of percutaneous arteriovenous fistula creation expand the scope of IR, this chapter reviews the clinical indications and preferences pertinent to dialysis access creation with respect to National Kidney Foundation Recommendations. Accesses remain imperfect, plagued by the development of flow-limiting intimal hyperplastic stenoses, and require monitoring and maintenance to minimize complications, morbidity and mortality. The measures of dialysis access function used in the surveillance of vascular accesses that indicate potential stenosis, and the utility of pre-occlusion recanalization of these stenoses are discussed. Complications specific to dialysis access interventions are also addressed.

scholarly journals Post-anastomotic venous stenosis after Optiflow deployment: An unexpected outcome

2019 ◽  
Vol 7 ◽  
pp. 2050313X1985100
Author(s):  
Ziad Al Adas ◽  
George Haddad ◽  
Bhavin C Patel ◽  
Lalathaksha Kumbar ◽  
Baha Al-Abid ◽  
...  
Keyword(s):  
Arteriovenous Fistula ◽  
End Stage Renal Disease ◽  
Hypertensive Nephropathy ◽  
New Device ◽  
The Past ◽  
Venous Stenosis ◽  
Stage Renal Disease ◽  
End Stage ◽  
Unexpected Outcome ◽  
First Time

Arteriovenous fistula failure represents a major cause of hospitalization and a significant economic burden for end-stage renal disease patients on hemodialysis. The Optiflow (Bioconnect Systems Inc., Ambler, PA) is a new device developed to improve arteriovenous fistula outcomes and decrease failure rates by reducing the risk of stenosis and improving maturation rates. This case report describes a 50-year-old male with hypertensive nephropathy on dialysis who had multiple arteriovenous fistula failures in the past. He was scheduled to undergo brachiocephalic fistula construction using the Optiflow device. After 8 months of use, the new fistula developed a peri-anastomotic venous stenosis, just distal to the Optiflow device. To our knowledge, this is the first time such a complication has been reported.

Plasma D‐Dimer Level and the Failure of Forearm Autologous Arteriovenous Fistula in Patients With End‐Stage Renal Disease

2019 ◽  
Vol 24 (4) ◽  
pp. 400-407
Author(s):  
Jing Du ◽  
Xianglei Kong ◽  
Liming Liang ◽  
Qinlan Chen ◽  
Lili Yin ◽  
...  
Keyword(s):  
Renal Disease ◽  
Arteriovenous Fistula ◽  
End Stage Renal Disease ◽  
Stage Renal Disease ◽  
End Stage ◽  
D Dimer

Predictive Factors for Unsuccessful Use of Arteriovenous Fistula in a Population of End-Stage Renal Disease Patients in Southeastern Mexico

2020 ◽  
Vol 62 ◽  
pp. 304-309
Author(s):  
Gustavo Martinez-Mier ◽  
Cecilia Camargo-Diaz ◽  
Marco Antonio Urbina-Velazquez ◽  
Sandro Fabricio Avila-Pardo
Keyword(s):  
Renal Disease ◽  
Arteriovenous Fistula ◽  
Predictive Factors ◽  
End Stage Renal Disease ◽  
Stage Renal Disease ◽  
End Stage

Strategies to Increase the Use of Autogenous Arteriovenous Fistula in End-Stage Renal Disease

1997 ◽  
Vol 11 (4) ◽  
pp. 397-405 ◽  
Author(s):  
A. Miller ◽  
T.J. Hölzenbein ◽  
M.N. Gottlieb ◽  
B.A. Sacks ◽  
P.T. Lavin ◽  
...  
Keyword(s):  
Renal Disease ◽  
Arteriovenous Fistula ◽  
End Stage Renal Disease ◽  
Stage Renal Disease ◽  
End Stage
Sign in / Sign up

Export Citation Format

Share Document